Menu

Blog

Aug 10, 2020

A biotech stock just rocketed 608% after announcing positive phase 3 trial data (MCRB)

Posted by in category: biotech/medical

Seres Therapeutics soared as much as 608% on Monday after the company announced positive phase 3 trial data for its drug SER-109 was de…

Leave a reply